| Groups |
HBV DNA (log IU/ml) |
eAg Seroconversion (%) |
| |
Baseline |
12 Wk |
24 Wk |
48 Wk |
Baseline |
12 Wk |
24 Wk |
48 Wk |
| Mono-Therapy TM (n= 30) |
6.26 ± 1.25 |
2.7± 1.3 |
1.82 ± 1.2 |
1.65 ± 0.69 |
- |
13% |
13% |
13% |
| Sequential Therapy SQT(n=28) |
6.61± 1.16 |
3.59 ± 1.4 |
2.1 3± 1.5 |
1.48 ± 0.9 |
- |
13% |
21% |
21.40% |
|
